Genotoxicity and Interference with Cell Cycle Activities by an Ethanolic Extract from Thai Plumbago indica Roots in Human Lymphocytes in vitro

  • Thitiorul, Sumon (Department of Preclinical Science, Faculty of Medicine, Thammasat University) ;
  • Ratanavalachai, Treetip (Department of Preclinical Science, Faculty of Medicine, Thammasat University) ;
  • Tanuchit, Sermkiat (Research Center, Faculty of Medicine, Thammasat University) ;
  • Itharat, Arunporn (Department of Applied Thai Traditional Medicine, Faculty of Medicine, Thammasat University) ;
  • Sakpakdeejaroen, Intouch (Department of Applied Thai Traditional Medicine, Faculty of Medicine, Thammasat University)
  • Published : 2013.04.30


In Thai traditional medicine, Plumbago indica or Jetamul-Pleung-Dang in Thai is known to have health benefit especially for anti-inflammatory, antibacterial, and antitumor activities. However, the mechanisms of its action are still uncertain. One of which might be genotoxic effects. In the present study, we investigated the genotoxicity of an ethanolic extract of Plumbago indica root (EEPIR) by sister chromatid exchange (SCE) assay in human lymphocytes. Results have shown that all treatments with EEPIR ($12.5-100{\mu}g/ml$) could induce cell cycle delay as shown by significant increase in the number of metaphase cells in the first cell cycle but neither in the second nor the third cell cycle. Only at concentrations of 25, 50, and $100{\mu}g/ml$ were SCE levels significantly increased above that of the control (p<0.05). EEPIR at a concentration of $500{\mu}g/ml$ induced cell death as few mitotic cells were shown. Accordingly, EEPIR ($25-100{\mu}g/ml$) is genotoxic in human lymphocytes and cytotoxic at concentrations of ${\geq}500{\mu}g/ml$ in vitro. Therefore, these activities of the EEPIR could serve its potential therapeutic effects, especially as an anticancer agent. Further study of EEPIR in vivo is now needed to support this in vitro evidence.


  1. Atjanasuppat K, Wongkham W, Meepowpan P, et al (2009). In vitro screening for anthelmintic and antitumour activity of ethnomedicinal plants from Thailand. J Ethnopharmacol, 123, 475-82.
  2. Azad CAK, Sushanta KC, Azad KAK (1982). Antifertility activity of Plumbago zeylanica Linn. root. Indian J Med Res, 76, 99-101.
  3. Aziz MH, Dreckschmidt NE, Verma AK (2008). Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. Cancer Res, 68, 9024-32.
  4. Durga R, Sridhar P, Polasa H (1992). Antimutagenic activity of plumbagin in Ames Salmonella typhimurium test. Indian J Med Res, 96, 143-5.
  5. Gomathinayagam R, Sowmyalakshmi S, Mardhatillah F, et al (2008). Anticancer mechanism of plumbagin, a natural compound, on non-small cell lung cancer cells. Anticancer Res, 28, 785-92.
  6. Jetty A, Subhakar C, Rajagopal D, et al (2010). Antimicrobial activities of neo-and 1-epineo-isoshinanolones from Plumbago zeylanica roots. Pharm Biol, 48, 1007-11.
  7. Kaewbumrung S, Panichayupakaranant P (2012). Isolation of three antibacterial naphthoquinones from Plumbago indica roots and development of a validated quantitative HPLC analytical method. Nat Prod Res, 26, 2020-3.
  8. Kato T, Watanabe M, Ohta T (1994). Induction of the SOS response and mutations by reactive oxygen-generating compounds in various Escherichia coli mutants defective in the mutM, mutY or soxRS loci. Mutagenesis, 9, 245-51.
  9. Kini DP, Pandey S, Shenoy BD, et al (1997). Antitumor and antifertility activities of plumbagin controlled release formulations. Indian J Exp Biol, 35, 374-9.
  10. Nguyen AT, Malonne H, Duez P, et al (2004). Cytotoxic constituents from Plumbago zeylanica. Fitoterapia, 75, 500-4.
  11. Perry P, Wolff S (1974). New Giemsa method for the differential staining of sister chromatids. Nature, 251, 156-8.
  12. Premakumari P, Rathinam K, Santhakumari G (1977). Antifertility activity of plumbagin. Indian J Med Res, 65, 829-38.
  13. Prieto-Alamo MJ, Abril N, Pueyo C (1993). Mutagenesis in Escherichia coli K-12 mutants defective in superoxide dismutase or catalase. Carcinogenesis, 14, 237-44.
  14. Ratanavalachai T, Thitiorul S, Tanuchit S, et al (2012). In vitro cytotoxic and genotoxic effects of ethanolic extract of Pikutbenjakul on human lymphocytes. Thamma Med J, 12, 262-8.
  15. Sharma I, Gusain D, Dixit VP (1991). Hypolipidaemic and antiatherosclerotic effects of plumbagin in rabbits. Indian J Physiol Pharmacol, 35, 10-4.
  16. Shieh JM, Chiang TA, Chang WT, et al (2010). Plumbagin inhibits TPA-induced MMP-2 and u-PA expressions by reducing binding activities of NF-kappaB and AP-1 via ERK signaling pathway in A549 human lung cancer cells. Mol Cell Biochem, 335, 181-93.
  17. SivaKumar V, Prakash R, Murali MR, et al (2005). In vivo micronucleus assay and GST activity in assessing genotoxicity of plumbagin in Swiss albino mice. Drug Chem Toxicol, 28, 499-507.
  18. Wang CC, Chiang YM, Sung SC, et al (2008). Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells. Cancer Lett, 259, 82-98.
  19. Xu KH, Lu DP (2010). Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo. Leuk Res, 34, 658-65.
  20. Zhang QR, Mei ZN, Yang GZ, Xiao YX (2007). Chemical constituents from aerial parts of Plumbago zeylanica Linn. Zhong Yao Cai, 30, 558-60.

Cited by

  1. Inhibitory Activities of Thai Medicinal Plants with Promising Activities Against Malaria and Cholangiocarcinoma on Human Cytochrome P450 vol.29, pp.12, 2015,